ResearchPod Summary
Controlled Ovarian Stimulation (COS) relies on gonadotropins like FSH and hCG to promote follicle development, yet the biological mechanisms driving a positive clinical response remain incompletely understood. This study aimed to identify molecular markers and structural changes in the granulosa cell secretome following gonadotropin stimulation to better understand their role in folliculogenesis.
The researchers utilized the KGN human granulosa-like tumor cell line to simulate the ovarian environment. Cells were treated with FSH, hCG, or a combination of both. The team performed a quantitative proteomic analysis of the cell culture media (the secretome) to identify differentially expressed proteins. To correlate these molecular changes with cell structure, they employed a novel 2D Fast Fourier Transform (FFT) method to quantify F-actin fiber aggregation and polymerization. Additionally, they assessed the activation of focal adhesion kinase (FAK) and Rho-associated kinase (ROCK-1), which are crucial for cellular signaling and cytoskeletal dynamics.
The proteomic analysis identified significant modulation in proteins associated with steroidogenesis, extracellular matrix (ECM) organization, and cytoskeleton remodeling. A notable finding was the specific upregulation of the semaphorin pathway, particularly semaphorin 7A, following the combined FSH/hCG treatment. Quantitative imaging revealed that all gonadotropin treatments led to massive F-actin reorganization, with specific increases in fiber polymerization. This structural change was supported by rapid activation (phosphorylation) of FAK and ROCK signaling pathways, suggesting that gonadotropins act through a precise sequence of signaling events to prime granulosa cells for maturation.
These results offer new molecular insights into how FSH and hCG work together to prepare follicles for ovulation. By identifying specific secretome markers and signaling pathways—such as semaphorin 7A—that are sensitive to hormonal combinations, this work provides a biological foundation for developing non-invasive markers to predict patient response in assisted reproductive technologies.
AI-generated third-party summary by ResearchPod. Not official content or an endorsement by the paper authors or affiliated organizations.